Search Results - "Gastroenterology (New York, N.Y. 1943)"

MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease by Eslam, Mohammed, Sanyal, Arun J., George, Jacob, Sanyal, Arun, Neuschwander-Tetri, Brent, Tiribelli, Claudio, Kleiner, David E., Brunt, Elizabeth, Bugianesi, Elisabetta, Yki-Järvinen, Hannele, Grønbæk, Henning, Cortez-Pinto, Helena, George, Jacob, Fan, Jiangao, Valenti, Luca, Abdelmalek, Manal, Romero-Gomez, Manuel, Rinella, Mary, Arrese, Marco, Eslam, Mohammed, Bedossa, Pierre, Newsome, Philip N., Anstee, Quentin M., Jalan, Rajiv, Bataller, Ramon, Loomba, Rohit, Sookoian, Silvia, Sarin, Shiv K., Harrison, Stephen, Kawaguchi, Takumi, Wong, Vincent Wai-Sun, Ratziu, Vlad, Yilmaz, Yusuf, Younossi, Zobair

“…Fatty liver associated with metabolic dysfunction is common, affects a quarter of the population, and has no approved drug therapy. Although pharmacotherapies…”
Get full text

Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization by Zuo, Tao, Zhang, Fen, Lui, Grace C.Y., Yeoh, Yun Kit, Li, Amy Y.L., Zhan, Hui, Wan, Yating, Chung, Arthur C.K., Cheung, Chun Pan, Chen, Nan, Lai, Christopher K.C., Chen, Zigui, Tso, Eugene Y.K., Fung, Kitty S.C., Chan, Veronica, Ling, Lowell, Joynt, Gavin, Hui, David S.C., Chan, Francis K.L., Chan, Paul K.S., Ng, Siew C.

“…Although severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infects gastrointestinal tissues, little is known about the roles of gut commensal…”
Get full text

Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry by Brenner, Erica J., Ungaro, Ryan C., Gearry, Richard B., Kaplan, Gilaad G., Kissous-Hunt, Michele, Lewis, James D., Ng, Siew C., Rahier, Jean-Francois, Reinisch, Walter, Ruemmele, Frank M., Steinwurz, Flavio, Underwood, Fox E., Zhang, Xian, Colombel, Jean-Frederic, Kappelman, Michael D.

“…The impact of Coronavirus disease 2019 (COVID-19) on patients with inflammatory bowel disease (IBD) is unknown. We sought to characterize the clinical course…”
Get full text

High-Fat Diet Promotes Colorectal Tumorigenesis Through Modulating Gut Microbiota and Metabolites by Yang, Jia, Wei, Hong, Zhou, Yunfei, Szeto, Chun-Ho, Li, Chuangen, Lin, Yufeng, Coker, Olabisi O., Lau, Harry Cheuk Hay, Chan, Anthony W.H., Sung, Joseph J.Y., Yu, Jun

“…Dietary fat intake is associated with increased risk of colorectal cancer (CRC). We examined the role of high-fat diet (HFD) in driving CRC through modulating…”
Get full text

Differences in Gut Microbiota in Patients With vs Without Inflammatory Bowel Diseases: A Systematic Review by Pittayanon, Rapat, Lau, Jennifer T., Leontiadis, Grigorios I., Tse, Frances, Yuan, Yuhong, Surette, Michael, Moayyedi, Paul

“…Altering the intestinal microbiota has been proposed as a treatment for inflammatory bowel diseases (IBDs), but there are no established associations between…”
Get full text

Strategies for Colorectal Cancer Screening by Ladabaum, Uri, Dominitz, Jason A., Kahi, Charles, Schoen, Robert E.

“…The incidence of colorectal cancer (CRC) is increasing worldwide. CRC has high mortality when detected at advanced stages, yet it is also highly preventable…”
Get full text

AGA Institute Rapid Review of the Gastrointestinal and Liver Manifestations of COVID-19, Meta-Analysis of International Data, and Recommendations for the Consultative Management of Patients with COVID-19 by Sultan, Shahnaz, Altayar, Osama, Siddique, Shazia M., Davitkov, Perica, Feuerstein, Joseph D., Lim, Joseph K., Falck-Ytter, Yngve, El-Serag, Hashem B.

“…Multiple gastrointestinal (GI) symptoms, including diarrhea, nausea/vomiting, and abdominal pain, as well as liver enzyme abnormalities, have been variably…”
Get full text

Deep Learning Localizes and Identifies Polyps in Real Time With 96% Accuracy in Screening Colonoscopy by Urban, Gregor, Tripathi, Priyam, Alkayali, Talal, Mittal, Mohit, Jalali, Farid, Karnes, William, Baldi, Pierre

“…The benefit of colonoscopy for colorectal cancer prevention depends on the adenoma detection rate (ADR). The ADR should reflect the adenoma prevalence rate,…”
Get full text

Alterations in Fecal Fungal Microbiome of Patients With COVID-19 During Time of Hospitalization until Discharge by Zuo, Tao, Zhan, Hui, Zhang, Fen, Liu, Qin, Tso, Eugene Y.K., Lui, Grace C.Y., Chen, Nan, Li, Amy, Lu, Wenqi, Chan, Francis K.L., Chan, Paul K.S., Ng, Siew C.

“…Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infects intestinal cells, and might affect the intestinal microbiota. We investigated changes in…”
Get full text

Bowel Disorders by Mearin, Fermín, Lacy, Brian E, Chang, Lin, Chey, William D, Lembo, Anthony J, Simren, Magnus, Spiller, Robin

“…Functional bowel disorders are highly prevalent disorders found worldwide. These disorders have the potential to affect all members of society, regardless of…”
Get full text

Efficacy of Dupilumab in a Phase 2 Randomized Trial of Adults With Active Eosinophilic Esophagitis by Hirano, Ikuo, Dellon, Evan S., Hamilton, Jennifer D., Collins, Margaret H., Peterson, Kathryn, Chehade, Mirna, Schoepfer, Alain M., Safroneeva, Ekaterina, Rothenberg, Marc E., Falk, Gary W., Assouline-Dayan, Yehudith, Zhao, Qiong, Chen, Zhen, Swanson, Brian N., Pirozzi, Gianluca, Mannent, Leda, Graham, Neil M.H., Akinlade, Bolanle, Stahl, Neil, Yancopoulos, George D., Radin, Allen

“…Eosinophilic esophagitis (EoE) is an allergen-mediated inflammatory disease with no approved treatment in the United States. Dupilumab, a VelocImmune-derived…”
Get full text

Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide by Piano, Salvatore, Singh, Virendra, Caraceni, Paolo, Maiwall, Rakhi, Alessandria, Carlo, Fernandez, Javier, Soares, Elza Cotrim, Kim, Dong Joon, Kim, Sung Eun, Marino, Monica, Vorobioff, Julio, Barea, Rita de Cassia Ribeiro, Merli, Manuela, Elkrief, Laure, Vargas, Victor, Krag, Aleksander, Singh, Shivaram Prasad, Lesmana, Laurentius Adrianto, Toledo, Claudio, Marciano, Sebastian, Verhelst, Xavier, Wong, Florence, Intagliata, Nicolas, Rabinowich, Liane, Colombato, Luis, Kim, Sang Gyune, Gerbes, Alexander, Durand, Francois, Roblero, Juan Pablo, Bhamidimarri, Kalyan Ram, Boyer, Thomas D., Maevskaya, Marina, Fassio, Eduardo, Kim, Hyoung Su, Hwang, Jae Seok, Gines, Pere, Gadano, Adrian, Sarin, Shiv Kumar, Angeli, Paolo, Bartoletti, Michele, Brodersen, Carlos, Bruns, Tony, de Man, Robert A., Fialla, Annette Dam, Gambino, Carmine, Gautam, Vikas, Girala, Marcos, Juanola, Adria, Kim, Jeong Han, Kim, Tae Hun, Kumar, Pramod, Lattanzi, Barbara, Lee, Tae Hee, Rinaldi Lesmana, Cosmas A., Moreau, Richard, Nath, Preetam, Navarro, Gustavo, Park, Ji-Won, Pinero, Gisela, Pyrsopoulos, Nikolaos T., Restellini, Sophie, Romero, Gustavo, Sacco, Marco, Sevá-Pereira, Tiago, Simón-Talero, Macarena, Song, Do Seon, Suk, Ki Tae, Van Vlierberghe, Hans, Yim, Sun Young, Yoon, Eileen Laurel, Zaccherini, Giacomo

“…Bacterial infections are common and life-threatening in patients with cirrhosis. Little is known about the epidemiology of bacterial infections in different…”
Get full text

HLA-DQA105 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn’s Disease by Kennedy, Nicholas A., Moutsianas, Loukas, Heap, Graham A., Chanchlani, Neil, Walker, Gareth J., Perry, Mandy H., Lees, Charlie W., Parkes, Miles, Mansfield, John C., McGovern, Dermot, Ahmad, Tariq, Patel, Vinod, Mazhar, Zia, Colleypriest, Ben, Weaver, Sean, Preston, Cathryn, Butt, Assad, Smith, Melissa, Beale, Amanda, Langlands, Sarah, Direkze, Natalie, Torrente, Franco, De La Revella Negro, Juan, Ewen MacDonald, Chris, Evans, Stephen M, Gunasekera, Anton V J, Thakur, Alka, Elphick, David, Shenoy, Achuth, Agrawal, Anurag, Bridger, Stephen, Cooper, Sheldon C, de Silva, Shanika, Mowat, Craig, Mayhead, Phillip, Lees, Charlie, Ahmad, Tariq, Russell, Richard K, Gervais, Lisa, Dunckley, Paul, Mahmood, Tariq, Banim, Paul J R, Sonwalkar, Sunil, Ghosh, Deb, Phillips, Rosemary H, Azaz, Amer, Sebastian, Shaji, Shenderey, Richard, Armstrong, Lawrence, Bell, Claire, Hariraj, Radhakrishnan, Matthews, Helen, Jafferbhoy, Hasnain, Selinger, Christian P, Willmott, Anne, Bloom, Stuart L, Chung-Faye, Guy, Harbord, Marcus, Hart, Ailsa, Lindsay, James O, Mawdsley, Joel E, McNair, Alistair, Murray, Charles D, Paul, Thankam, Pollok, Richard, Shah, Neil, Johnson, Matt W, Modi, Anita, Dawa Kabiru, Kasamu, Baburajan, B K, Bhaduri, Bim, Adebayo Fagbemi, Andrew, Limdi, Jimmy K, Ramadas, Arvind, MacFaul, George, Mansfield, John, Morris, Mary-Anne, Tremelling, Mark, Hawkey, Chris, Charlton, Charles PJ, Rodrigues, Astor, Snook, Jonathon, De Silva, Aminda N, Smith, Mark S, Panter, Simon, Cummings, Fraser, Mahmood, Zahid, Sen, Sandip, Pigott, Anna J, Hobday, David, Wesley, Emma, Beckly, John, Vani, Deven, Ramakrishnan, Subramaniam, Chaudhary, Rakesh, Trudgill, Nigel J, Cooney, Rachel, Bell, Andy, Li, Andy, Gore, Stephen

“…Anti–tumor necrosis factor (anti-TNF) therapies are the most widely used biologic drugs for treating immune-mediated diseases, but repeated administration can…”
Get full text

Gastroduodenal Disorders by Stanghellini, Vincenzo, Talley, Nicholas J, Chan, Francis, Hasler, William L, Malagelada, Juan, Suzuki, Hidekazu, Tack, Jan

“…Symptoms that can be attributed to the gastroduodenal region represent one of the main subgroups among functional gastrointestinal disorders. A slightly…”
Get full text

Prevalence and Characteristics of Gastrointestinal Symptoms in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection in the United States: A Multicenter Cohort Study by Redd, Walker D., Zhou, Joyce C., Hathorn, Kelly E., McCarty, Thomas R., Bazarbashi, Ahmad Najdat, Thompson, Christopher C., Shen, Lin, Chan, Walter W.

Get full text

Enterotoxigenic Bacteroides fragilis Promotes Intestinal Inflammation and Malignancy by Inhibiting Exosome-Packaged miR-149-3p by Cao, Yingying, Wang, Zhenhua, Yan, Yuqing, Ji, Linhua, He, Jie, Xuan, Baoqin, Shen, Chaoqin, Ma, Yanru, Jiang, Shanshan, Ma, Dan, Tong, Tianying, Zhang, Xinyu, Gao, Ziyun, Zhu, Xiaoqiang, Fang, Jing-Yuan, Chen, Haoyan, Hong, Jie

Get full text

Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening by Ratziu, Vlad, Harrison, Stephen, Francque, Sven, Bedossa, Pierre, Lehert, Philippe, Serfaty, Lawrence, Romero-Gomez, Manuel, Boursier, Jérôme, Abdelmalek, Manal, Caldwell, Steve, Drenth, Joost, Anstee, Quentin, Hum, Dean, Hanf, Remy, Roudot, Alice, Megnien, Sophie, Staels, Bart, Sanyal, Arun

“…Background & Aims Elafibranor is an agonist of the peroxisome proliferator−activated receptor-α and peroxisome proliferator−activated receptor-δ. Elafibranor…”
Get full text

Effects of Nutritional Prehabilitation, With and Without Exercise, on Outcomes of Patients Who Undergo Colorectal Surgery: A Systematic Review and Meta-analysis by Gillis, Chelsia, Buhler, Katherine, Bresee, Lauren, Carli, Francesco, Gramlich, Leah, Culos-Reed, Nicole, Sajobi, Tolulope T., Fenton, Tanis R.

“…Although there have been meta-analyses of the effects of exercise-only prehabilitation on patients undergoing colorectal surgery, little is known about the…”
Get full text

Famotidine Use Is Associated With Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study by Freedberg, Daniel E., Conigliaro, Joseph, Wang, Timothy C., Tracey, Kevin J., Callahan, Michael V., Abrams, Julian A., Sobieszczyk, Magdalena E., Markowitz, David D., Gupta, Aakriti, O’Donnell, Max R., Li, Jianhua, Tuveson, David A., Jin, Zhezhen, Turner, William C., Landry, Donald W.

Get full text

Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension by Chalasani, Naga, Abdelmalek, Manal F., Garcia-Tsao, Guadalupe, Vuppalanchi, Raj, Alkhouri, Naim, Rinella, Mary, Noureddin, Mazen, Pyko, Maxmillan, Shiffman, Mitchell, Sanyal, Arun, Allgood, Adam, Shlevin, Harold, Horton, Rex, Zomer, Eliezer, Irish, William, Goodman, Zachary, Harrison, Stephen A., Traber, Peter G., Abdelmalek, Manal, Balart, Luis, Borg, Brian, Chalasani, Naga, Charlton, Michael, Conjeevaram, Hari, Fuchs, Michael, Ghalib, Reem, Gholam, Pierre, Halegoua-De Marzio, Dina, Harrison, Stephen, Jue, Christopher, Kemmer, Nyingi, Kowdley, Kris, Lai, Michelle, Lawitz, Eric, Loomba, Rohit, Noureddin, Mazen, Paredes, Angelo, Rinella, Mary, Rockey, Don, Rodriguez, Miguel, Rubin, Raymond, Ryan, Michael, Sanyal, Arun, Scanga, Andrew, Sepe, Thomas, Shiffman, Mitchell, Tetri, Brent, Thuluvath, Paul, Torres, Dawn, Vierling, John, Wattacheril, Julia, Weiland, Amanda, Zogg, Donald

“…Increased levels of galectin 3 have been associated with nonalcoholic steatohepatitis (NASH) and contribute to toxin-induced liver fibrosis in mice. GR-MD-02…”
Get full text